You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 3, March 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (43)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmological Disorders, Other
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phenotypic Subtypes of Stargardt Macular Dystrophy–Fundus Flavimaculatus

Noemi Lois, MD, PhD; Graham E. Holder, PhD; Catey Bunce, MSc; Fredrick W. Fitzke, PhD; Alan C. Bird, MD

Arch Ophthalmol. 2001;119:359-369.

Objective  To determine if phenotypic subtypes exist in Stargardt macular dystrophy–fundus flavimaculatus (SMD-FFM).

Methods  A cross-sectional study of 63 patients with autosomal recessive SMD-FFM was undertaken. The age of onset, duration of symptoms, visual acuity, and clinical features on fundus examination, color fundus photographs, and fundus autofluorescence images were recorded. Electrophysiological tests, including pattern, focal, and full-field electroretinogram (ERG), electro-oculogram, and color-contrast sensitivity measurement, were also performed.

Results  Based on electrophysiological attributes (ERG), patients with SMD-FFM could be classified into 3 groups. In group 1, there was severe pattern ERG abnormality with normal scotopic and full-field ERGs. In group 2, there was additional loss of photopic function, and in group 3, there was loss of both photopic and scotopic function. Differences in scotopic or photopic function among groups were not explained on the basis of differences in age of onset or duration of disease.

Conclusions  Patients with SMD-FFM can be classified into 3 groups based on the absence or presence of generalized loss of either photopic or photopic and scotopic function. It appears that these 3 groups may represent distinct phenotypic subtypes in SMD-FFM.


From the Medical Retinal Service (Drs Lois and Bird) and Departments of Electrodiagnostics (Dr Holder) and Epidemiology (Ms Bunce), Moorfields Eye Hospital, and Department of Visual Science, Institute of Ophthalmology (Dr Fitzke), London, England. Dr Lois is now with the Retina Service, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pattern electroretinography of larger stimulus field size and spectral-domain optical coherence tomography in patients with Stargardt disease
Lenassi et al.
Br J Ophthalmol 2009;93:1600-1605.
ABSTRACT | FULL TEXT  

Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence
Rath et al.
Br J Ophthalmol 2008;92:623-629.
ABSTRACT | FULL TEXT  

Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy
Robson et al.
Br J Ophthalmol 2008;92:95-102.
ABSTRACT | FULL TEXT  

Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus
Boon et al.
Br J Ophthalmol 2007;91:1504-1511.
ABSTRACT | FULL TEXT  

Homozygosity for a Novel ABCA4 Founder Splicing Mutation Is Associated with Progressive and Severe Stargardt-like Disease
Beit-Ya'acov et al.
IOVS 2007;48:4308-4314.
ABSTRACT | FULL TEXT  

Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography
Querques et al.
Br J Ophthalmol 2006;90:1157-1162.
ABSTRACT | FULL TEXT  

Fundus Autofluorescence and mfERG for Early Detection of Retinal Alterations in Patients Using Chloroquine/Hydroxychloroquine.
Kellner et al.
IOVS 2006;47:3531-3538.
ABSTRACT | FULL TEXT  

Fundus autofluorescence in age-related macular degeneration: an epiphenomenon?
Hopkins et al.
IOVS 2006;47:2269-2271.
FULL TEXT  

Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity.
Robson et al.
Br J Ophthalmol 2006;90:472-479.
ABSTRACT | FULL TEXT  

Comparison of Fundus Autofluorescence with Photopic and Scotopic Fine-Matrix Mapping in Patients with Retinitis Pigmentosa and Normal Visual Acuity
Robson et al.
IOVS 2004;45:4119-4125.
ABSTRACT | FULL TEXT  

The genetics of inherited macular dystrophies
Michaelides et al.
J. Med. Genet. 2003;40:641-650.
ABSTRACT | FULL TEXT  

Pattern ERG Correlates of Abnormal Fundus Autofluorescence in Patients with Retinitis Pigmentosa and Normal Visual Acuity
Robson et al.
IOVS 2003;44:3544-3550.
ABSTRACT | FULL TEXT  

Evolutionarily Conserved ELOVL4 Gene Expression in the Vertebrate Retina
Lagali et al.
IOVS 2003;44:2841-2850.
ABSTRACT | FULL TEXT  

Altered Recovery of Macular Function after Bleaching in Stargardt's Disease-Fundus Flavimaculatus: Pattern VEP Evidence
Parisi et al.
IOVS 2002;43:2741-2748.
ABSTRACT | FULL TEXT  

Spectral Profiling of Autofluorescence Associated with Lipofuscin, Bruch's Membrane, and Sub-RPE Deposits in Normal and AMD Eyes
Marmorstein et al.
IOVS 2002;43:2435-2441.
ABSTRACT | FULL TEXT  

Clinical Variations in Assessment of Bull's-eye Maculopathy
Kurz-Levin et al.
Arch Ophthalmol 2002;120:567-575.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.